Eli Lilly's Omvoh (mirikizumab) has shown durable disease clearance over four years in patients with moderately to severely ...

An experimental monoclonal antibody treatment appears to ease the digestive disorder ulcerative colitis in patients who've failed other medications, a new trial shows. The treatment, tulisokibart, ...

Ulcerative colitis treatment drug Omvoh, from Eli Lilly, was linked to sustained clinical remission after 4 years, according to new trial data. Image credit: Plexi Images/GHI/UCG/Universal Images ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted ...

A drug that has already gained FDA approval for the treatment of ulcerative colitis is also effective in the treatment of Crohn’s, new data suggest. Brothers91/Getty Images Recently, the drug’s ...

How Does Tremfya Work for Ulcerative Colitis? Tremfya is a monoclonal antibody that reduces inflammation. The main ingredient in Tremfya is a medicine called guselkumab. This medicine blocks a ...

For some people, relief can last years. For others, only a few weeks. Learn what to do to stay in remission for as long as possible.

Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...

DOCTOR, IT’S NOT QUITE KNOWN WHAT CAUSES ULCERATIVE COLITIS, BUT IF YOU’RE A WOMAN OF CHILDBEARING AGE, YOU SHOULD ESPECIALLY KEEP AN EYE OUT FOR THE SYMPTOMS AS 11 NEWS. ANCHOR LACEE GRIFFITH ...

Arthritis is the most common nonintestinal complication for people with ulcerative colitis (UC). These tips can help stave it ...

Unfortunately the cause of ulcerative colitis is unknown, although both genetic and the environmental causes have been proposed. Most patients with ulcerative colitis do not have anyone else in the ...